BlossomHill Therapeutics Stock (NASDAQ:BLSM)
Previous Close
$18.46
52W Range
$15.25 - $19.52
50D Avg
$16.50
200D Avg
$16.50
Market Cap
$567.37M
Avg Vol (3M)
$364.19K
Beta
-
Div Yield
-
BLSM Company Profile
Blossomhill Therapeutics, Inc. is a biopharmaceutical company. It engages in the development of small molecule medicines for unmet medical needs in cancer treatment. The company was founded in June 2020 and is headquartered in San Diego, CA.